3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Anal Cancer Metastatic
1
Interventions
Oxaliplatin
6
Capecitabine
6
Fluorouracil
5
Leucovorin
4
trastuzumab deruxtecan
3
pembrolizumab
3
cemiplimab
3
Cisplatin
3
zolbetuximab
2
fludarabine
2
durvalumab
2
Trastuzumab
2
Ramucirumab
2
Paclitaxel
2
Cyclophosphamide
2
tucatinib
1
repotrectinib
1
paricalcitol
1
lenvatinib
1
enzalutamide
1
darolutamide
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Vinorelbine
1
Transurethral Resection of Prostate
1
Taxes
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.